Cardiovascular Abnormalities
Conditions
Brief summary
This study will measure the efficacy and safety of an early postoperative anticoagulation self-management program, using the CoaguChek S device, in patients undergoing mechanical valve replacements. Patients will be randomized into a study group (self-management) or a control group (physician management).
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* adult patients, 18-70 years of age; * recipient of a mechanical heart valve (aortic and/or mitral), +/- CABG, +/- postoperative atrial fibrillation.
Exclusion criteria
* recipient of a bioprosthetic valve; * post-operative thrombotic events; * pre-operative utilization of oral anticoagulation.
Countries
Canada